SLA
Click for more information
0.00% $3.34 silk laser australia limited

ropren fails june approval

  1. tharlow
    580 Posts.
    clock Created with Sketch.
    28/06/07
    17:44
    Post #: 2577790
    What now for Solagran? Now that the directors realise the Russian Ministry of Health is not going to roll over without a full Phase III trial, are the directors trying to prop-up the price ahead of a capital raising?

    I'd be wary of the downside here.
    SLA Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.